Physician profile
Michael David Barton, JR.
NPI 1093987679
$889.08
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $173 · 2021: $121 · 2023: $163 · 2024: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $200 · Gift: $140 · Food and Beverage: $75.90 · Honoraria: $36.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $200.00 |
| Gift | $140.43 |
| Food and Beverage | $75.90 |
| Honoraria | $36.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $301.04 | 2019-2023 | Itero Element 5d Plus |
| Dentsply LLC | $200.00 | 2024 | |
| Ultradent Products INC | $151.45 | 2023 | Opalescence |
| Benco Dental Supply Co. | $85.32 | 2019-2024 | |
| Dentsply Sirona INC | $41.41 | 2019-2021 | |
| Pulpdent Corporation | $35.44 | 2024 | |
| Voco America INC. | $33.04 | 2019-2020 | |
| Solventum Corporation | $17.71 | 2024 | 3m Espe Filtek Supreme Ultra Universal Restorative |
| Orapharma, A Division of Bausch Health US, LLC | $12.78 | 2020 | |
| Gc America INC. | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.